Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesAdministrative/Operational PolicyBaylor Scott & White Prior Auth/Notification List …
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentBaylor Scott & White Health PlanPolicy N/A

    Commercial Prior Authorization / Notification List (partial)

    Customize your policy alerts

    Sign up for all Baylor Scott & White Health Plan policy alerts

    Know when Baylor Scott & White Health Plan releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Lists CPT/procedure codes requiring prior authorization or notification for BSWHP commercial products; explains portal submission and benefit verification requirements; affects network providers submitting authorization requests for commercial members.

    Policy Summary
    PayerBaylor Scott & White Health Plan
    PolicyCommercial Prior Authorization / Notification List (partial)
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJun 1, 2026
    Next Review DateN/A
    Key ActionSubmit prior authorization requests via the secure provider portal and verify member benefits before providing services.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    06/01/2026Effective
    Commercial HMO/PPO/EPOProduct
    Multiple CPTsCode focus
    Not guaranteeAuthorization caveat

    Coverage determinations and code inclusions

    Coverage determination notes (partial)

    Coverage and authorization stance (partial):

    Prior Authorization is required for services listed; submission available via the secure provider portal. Prior authorization is not a guarantee of benefits or payment and reimbursement is dependent upon eligibility, benefit limitations/exclusions and member plan benefits.

    Codes requiring prior authorization/notification (partial)

    This segment enumerates specific CPT procedure codes that require the payer's prior authorization or notification as part of the commercial PA/notification list.

    The codes listed in the commercial prior authorization/notification list require prior authorization or notification as indicated by the payer; each code line may include an associated effective or mapping date.

    Prior authorization/notification code list (partial)

    This partial list identifies CPT codes that are subject to the payer's prior authorization or notification requirements; each code entry includes an associated effective date.

    Specific procedure codes (examples include knee arthroscopy/arthroplasty codes 29867–29871, 29874–29889, hip arthroscopy 29914–29916, rhinoplasty codes 30400–30468, nasal repair 31660–32672, venous procedures 36465–36483, and transplant/HPC codes 38240–38241) are included on the list and have associated effective dates noted.

    Code list (excerpt)

    This excerpt enumerates procedure codes subject to prior authorization/notification; no specific clinical coverage criteria are provided in these chunks.

    Example entries include transplant preparation codes 38240 and 38241 and mappings for unlisted procedures (eg, 40799) with effective dates shown in the list.

    Coverage stance for listed CPT codes

    The excerpt lists CPT codes subject to prior authorization or notification and often includes associated dates; no detailed clinical criteria are present in this segment.

    Spinal decompression/laminectomy/laminotomy codes (eg, 63003–63035), interventional pain/injection codes (eg, 64484, 64490–64493), ENT/craniofacial and imaging codes (eg, 69705–69716, 704xx, 705xx) and various imaging groups are listed with effective dates indicating inclusion on the PA/notification list.

    Listed CPT codes requiring prior authorization/notification

    This excerpt enumerates CPT codes and, where present, associated effective/mapping dates which indicate inclusion on the payer's prior authorization/notification list.

    Imaging and cardiac imaging CPT groups (eg, 70543–70555, 71250–71275, 72125–72159, 75561–75571) and therapeutic radiology planning codes (77262–77332 series) are included on the list with effective dates recorded for many entries.

    Prior authorization/notification inclusion (partial)

    This excerpt enumerates CPT codes that are included on the commercial prior authorization/notification list; inclusion implies these services require prior authorization or notification per payer policy.

    Therapeutic radiology treatment planning (e.g., 77306–77332), brachytherapy/hyperthermia codes (e.g., 77600–77799), and myocardial PET/SPECT codes (e.g., 78012–78494) are listed and require prior authorization/notification as shown.

    Coverage criteria and panel content requirements

    For many molecular pathology panels, the list specifies required minimum gene content or scope for the panel to be recognized on the list.

    ALL of the following

    • Aortic dysfunction/dilation panels must include sequencing of at least 9 genes, including FBN1, TGFBR1, TGFBR2, COL3A1, MYH11, ACTA2, SLC2A10, SMAD3, and MYLK.
    • Hearing loss genomic panels must include sequencing of at least 60 genes (examples include CDH23, CLRN1, GJB2, GPR98, MTRNR1, MYO7A, MYO15A, PCDH15, OTOF, SLC26A4, TMC1, TMPRSS3, USH1C, USH1G, USH2A, WFS1).
    • Drug metabolism/pharmacogenomics genomic panels must include testing of at least 6 genes including CYP2C19 and CYP2D6 and must include CYP2D6 duplication/deletion analysis.

    Coverage entries in this segment

    This extract lists CPT codes with associated test/panel descriptions and any specified panel size or analysis requirements; it indicates which services are included in the prior authorization/notification list.

    Selected molecular pathology CPTs (eg, 81430–81443) and expanded genomic panel entries (eg, 81455–81464) are listed with panel descriptions and gene-count or analysis requirements; gene-expression/assay CPTs (eg, 81503–81560 series) and their algorithmic outputs are also enumerated on the list.

    Code listing and reference — no clinical criteria in this segment

    This portion of the policy provides code-level entries and brief descriptions; specific coverage determinations, criteria, or prior authorization requirements are referenced by code and effective date but detailed clinical criteria are not present in this segment.

    Examples include PLA/U codes (0001U, 0003U, 0005U) and other proprietary codes with descriptions and effective dates; these codes are included on the PA/notification list as shown but do not include standalone clinical criteria in this excerpt.

    Codes requiring prior authorization/notification (partial list)

    This section is a code list used to indicate services that require prior authorization or notification per the commercial prior authorization/notification policy.

    Multiple U- and T- proprietary codes (examples include 0122U, 0130U, 0152U, 0211U, 0244U, 0279U, 0334U) for infectious disease, hematology, and oncology genomic assays are listed with effective dates indicating PA/notification requirements.

    Listed services subject to authorization/notification (partial list)

    The document window enumerates services and tests that are subject to prior authorization/notification and provides effective dates; clinical applicability and criteria are implied by the service descriptions (eg, oncology MRD assays, genomic panels, infectious agent ddPCR).

    Selected entries include hematology genomic panels (0271U–0279U series), red blood cell antigen typing (0283U–0288U), and oncology targeted genomic sequence analyses (0334U series) which are on the PA/notification list with recorded effective dates.

    Listings without embedded coverage criteria (partial)

    This partial section enumerates specific procedure and laboratory test codes and brief descriptions; it does not include explicit coverage criteria text in these chunks.

    Sample entries include radiostereometric analysis (0350T), APOL1 risk variant testing (0355U), various optical coherence tomography and bioassay T/U codes (0351T–0356U), and oncology NGS/digital PCR panels (0473U, 0478U) that require PA/notification per the list.

    Prior authorization/notification code list (partial)

    This section enumerates codes that require prior authorization or notification for commercial members; specific coverage criteria are maintained elsewhere in the policy set.

    Examples include device evaluation 0473T and large oncology NGS panels 0473U (648 genes) and hereditary pan-cancer panel 0474U (88 genes) noted with effective dates; these entries indicate inclusion on the PA/notification list but do not provide standalone coverage rules here.

    Code listing continuation — no standalone criteria in this excerpt

    Continuation of code and descriptor listings (no explicit coverage rules or criteria in this segment).

    The continuation lists temporary and category III codes (e.g., 0588T–0599T, 0600T–0606T) with effective dates that are included on the PA/notification list; clinical criteria, if any, are not embedded in this excerpt.

    CPT, HCPCS, and proprietary codes (grouped)

    Selected CPT codes requiring prior authorization/notification (partial list)CPTCovered
    00170Anesthesia for intraoral procedures, including biopsy; not otherwise specified.
    11950Subcutaneous injection of filling material (eg, collagen); 1 cc or less.
    11951Subcutaneous injection of filling material (eg, collagen); 1.1 to 5.0 cc.
    11952Subcutaneous injection of filling material (eg, collagen); 5.1 to 10.0 cc.
    11954Subcutaneous injection of filling material (eg, collagen); over 10.0 cc.
    14041Adjacent tissue transfer or rearrangement; defect 10.1 sq cm to 30.0 sq cm.
    14301Adjacent tissue transfer; defect 30.1 sq cm to 60.0 sq cm.
    15100Split-thickness autograft, trunk, arms, legs; first 100 sq cm or less.
    15200Full thickness graft, free, including direct closure of donor site, trunk; 20 sq cm or less.
    15771Grafting of autologous fat harvested by liposuction technique to trunk, breasts, scalp, arms, and/or legs; 50 cc or less injectate.
    1–10 of 18
    1/2
    Spine procedures (selected)CPT
    22515Percutaneous vertebral augmentation (kyphoplasty), 1 vertebral body
    22526Percutaneous intradiscal electrothermal annuloplasty; single level
    22527Percutaneous intradiscal electrothermal annuloplasty; additional levels
    22532Arthrodesis, lateral extracavitary technique; thoracic
    22533Arthrodesis, lateral extracavitary technique; lumbar
    Spinal instrumentation and disc arthroplastyCPT
    22841Internal spinal fixation by wiring of spinous processes (add-on)
    22842Posterior segmental instrumentation; 3 to 6 vertebral segments
    22853Insertion of interbody biomechanical device(s) with integral anterior instrumentation
    22856Total disc arthroplasty, cervical; single interspace
    Shoulder/rotator cuff/arthroplasty proceduresCPT
    23410Open repair of ruptured rotator cuff; acute
    23412Open repair of ruptured rotator cuff; chronic
    23470Glenohumeral joint hemiarthroplasty
    23472Total shoulder arthroplasty
    Hip and knee arthroplasty; shoulder and knee arthroscopy (selected)CPT
    27125Hemiarthroplasty, hip, partial (mapped in list)
    27130Total hip arthroplasty (mapped in list)
    27486Arthroplasty, knee, condyle and plateau; medial AND lateral compartments (total knee arthroplasty)
    27438Arthroplasty, patella; with prosthesis
    29805Arthroscopy, shoulder, diagnostic
    29827Arthroscopy, shoulder, with rotator cuff repair
    Arthroscopy codes (shoulder, hip, knee)CPT
    29819Arthroscopy, shoulder, with removal of loose body
    29822Arthroscopy, shoulder, debridement, limited
    29866Arthroscopy, knee, osteochondral autograft(s)
    29874Arthroscopy, knee, with lateral release
    Knee arthroscopy/arthroplasty codes (examples)CPTCovered
    29867Arthroscopy, knee, surgical; osteochondral allograft (eg, mosaicplasty)
    29868Arthroplasty, knee, condyle and plateau; medial AND lateral compartments (total knee arthroplasty) / meniscal transplantation
    29870Arthroscopy, knee, diagnostic, with or without synovial biopsy
    29871Arthroscopy, knee, surgical; for infection, lavage and drainage
    Rhinoplasty and nasal valve repair codesCPTCovered
    30400Rhinoplasty, primary; lateral and alar cartilages and/or elevation of nasal tip
    30410Rhinoplasty, primary; complete, external parts including bony pyramid
    30420Rhinoplasty, primary; including major septal repair
    30468Repair of nasal valve collapse with implant(s)
    Endovenous/venous ablation codesCPTCovered
    36465Injection of non-compounded foam sclerosant; single incompetent extremity truncal vein
    36473Endovenous ablation therapy, mechanochemical; first vein treated
    36483Endovenous ablation with chemical adhesive; first vein treated
    Selected procedure codes from excerptCPT
    38240Transplant preparation of hematopoietic progenitor cells; cell concentration in plasma, mononuclear, or buffy coat layer = Hematopoietic progenitor cell (HPC); allogeneic transplantation per donor.
    38241Transplant preparation of hematopoietic progenitor cells; ... = Hematopoietic progenitor cell (HPC); autologous transplantation.
    40799Unlisted procedure, lips (mapped here to transplant prep entry in list).
    Unlisted-procedure mappingsCPT
    44135Unlisted procedure, stomach = Intestinal allotransplantation; from cadaver donor.
    44705Unlisted procedure, stomach = Preparation of fecal microbiota for instillation, including assessment of donor specimen.
    Spinal decompression/laminectomy/laminotomy codesCPTCovered
    63003Laminectomy/related spinal decompression procedures (various segments/regions) as listed
    63005Laminectomy with exploration and/or decompression, lumbar, 1-2 segments
    63012Laminectomy with removal of abnormal facets/pars for spondylolisthesis, lumbar (Gill type)
    63015Laminectomy, cervical, more than 2 segments
    63017Laminectomy, lumbar, more than 2 segments
    63020Laminotomy with decompression, cervical (1 interspace)
    63030Laminotomy with decompression, lumbar (1 interspace)
    63035Each additional interspace cervical or lumbar (add-on)
    Neurostimulator implantation and generator codesCPTCovered
    63650Percutaneous implantation of neurostimulator electrode array, epidural
    63655Laminectomy for implantation of neurostimulator electrodes, plate/paddle, epidural
    63685Insertion/replacement of spinal neurostimulator pulse generator
    64590Insertion/replacement of peripheral/sacral/gastric neurostimulator pulse generator
    Injection, nerve ablation and related interventional pain codesCPTCovered
    64454Genicular nerve branch injection(s) with imaging guidance
    64479Transforaminal epidural injection, cervical/thoracic, single level with imaging guidance
    64484Transforaminal epidural injection, lumbar/sacral, single level
    64510Injection; stellate ganglion (cervical sympathetic)
    64628Thermal destruction of intraosseous basivertebral nerve (first 2 vertebral bodies)
    64629Thermal destruction of intraosseous basivertebral nerve each additional vertebral body
    ENT, craniofacial and imaging codes (CT/MRI)CPTCovered
    69705Nasopharyngoscopy with Eustachian tube dilation (unilateral)
    69706Nasopharyngoscopy with Eustachian tube dilation (bilateral)
    70450CT head/brain without contrast
    70460CT head/brain with contrast
    70551MRI brain without contrast
    70552MRI brain with contrast
    Imaging and therapeutic radiology CPT groupsCPT | mixed
    70543-70555Magnetic resonance angiography and MRI brain/neck/head related CPT codes listed in excerpt
    71250-71275CT thorax and CTA chest codes referenced
    72125-72159CT/MR spine and related codes
    73200-73225CT/MR upper extremity and angiography codes
    73700-73725CT/MR lower extremity and angiography codes
    74150-74185CT/MR abdomen and pelvis codes
    75557-75577Cardiac MRI/CT and related codes
    76376-763913D rendering and MR spectroscopy/elastography codes
    77262-77370Therapeutic radiology treatment planning and related codes
    Therapeutic radiology planningCPT
    77306Therapeutic radiology treatment planning; simple (teletherapy isodose plan)
    77307Therapeutic radiology treatment planning; complex (teletherapy isodose plan; multiple areas or special beam considerations)
    77316Therapeutic radiology treatment planning; brachytherapy isodose plan; simple
    77317Therapeutic radiology treatment planning; brachytherapy isodose plan; intermediate
    77318Therapeutic radiology treatment planning; brachytherapy isodose plan; complex
    77321Special teletherapy port plan, particles, hemibody, total body
    77331Special dosimetry (e.g., TLD, microdosimetry) when prescribed
    77332Treatment devices, design and construction; simple
    Radiation delivery and devicesCPT
    77333Treatment devices, intermediate
    77334Treatment devices, complex
    77336Continuing medical physics consultation, reported per week
    77338Multi-leaf collimator device(s) for IMRT
    77372Radiation treatment delivery, stereotactic radiosurgery (SRS), 1 session
    77402Radiation treatment delivery; Level 1 including imaging guidance when performed
    77407Radiation treatment delivery; Level 2, single-isocenter photons including imaging guidance
    77412Radiation treatment delivery; Level 3, multiple isocenters or single-isocenter with active motion management
    Hyperthermia and brachytherapyCPT
    77600Hyperthermia, externally generated; superficial
    77605Hyperthermia, externally generated; deep
    77750Infusion or instillation of radioelement solution
    77761Intracavitary radiation source application; simple
    77762Intracavitary radiation source application; intermediate
    77763Intracavitary radiation source application; complex
    77767Remote afterloading HDR radionuclide skin surface brachytherapy; lesion up to 2.0 cm or 1 channel
    Nuclear medicine and cardiac imagingCPT
    78012Thyroid uptake quantitative measurement(s)
    78013Thyroid imaging
    78103Bone marrow imaging; multiple areas
    78300Bone and/or joint imaging; limited area
    78430Myocardial imaging, PET perfusion study; single study with CT transmission scan
    78451Myocardial perfusion imaging, tomographic (SPECT); single study
    78494Myocardial PET perfusion multiple studies = cardiac blood pool imaging, gated equilibrium, SPECT
    Nuclear medicine / radiopharmaceutical codesCPT
    78605-78660, 78699Myocardial imaging PET perfusion and related nuclear medicine procedures mapped to various brain, CSF, vascular flow, and other imaging procedure descriptions in list excerpt.
    78700-78730, 78761Kidney and urinary tract nuclear medicine studies and related mappings (morphology, function, residual, reflux, testicular imaging).
    78800-78832, 78831-78832Radiopharmaceutical localization and PET imaging codes with planar, tomographic, whole body, and SPECT descriptions.
    Molecular pathology / genetic testing codesCPT
    81161-81167, 81175, 81194Genetic test codes (BRCA, dystrophin, ASXL1, NTRK) listed with effective dates.
    81201-81226Gene-specific analyses (APC, BRAF, BRCA variants, CFTR, CYP2C19, CYP2D6, etc.) with dates.
    81301-81351Genomic/cytogenomic and related analyses (microsatellite instability, MECP2, PALB2, SLCO1B1, SMN1, TP53, etc.) with dates.
    81408-81443Molecular pathology procedure levels and multi-gene panel descriptions (exome, genome, condition-specific panels) with required gene lists and dates.
    Selected molecular pathology CPTsCPTCovered
    81430Molecular pathology procedure (single gene/exon-level analyses) referenced for hearing loss genes
    81431Molecular pathology Level 8; genomic panels for hearing loss including duplication/deletion and copy number analyses
    81439Molecular pathology Level 8; hereditary cardiomyopathy panels, sequencing of at least 5 cardiomyopathy-related genes
    81442Molecular pathology Level 8; Noonan spectrum disorder panels, sequencing of at least 12 specified genes
    Gene expression/assay CPTsCPT
    81503mRNA gene expression profiling (ex: coronary artery disease mapping to oncology ovarian assay described)
    81519mRNA gene expression profiling for oncology (breast) — 21-gene recurrence score referenced
    81541mRNA gene expression profiling for prostate, 46 genes, disease-specific mortality risk score
    Example PLA/U codes and descriptionsmixed
    0001URed blood cell antigen typing, DNA, human erythrocyte antigen gene analysis of 35 antigens from 11 blood groups
    0003UOncology (ovarian) biochemical assays of five proteins, algorithm reported as a likelihood score
    0005UOncology (prostate) gene expression profile by RT-PCR of 3 genes, urine, algorithm reported as risk score
    Example T/U and other specialized codesmixed
    0054UPrescription drug monitoring, 14+ classes, definitive tandem mass spectrometry, capillary blood, quantitative report
    0071TFocused ultrasound ablation of uterine leiomyomata, MR guidance; total volume <200 cc
    Selected U/T codes in excerptmixed
    0122UInfectious agent detection and identification, targeted sequence analysis (16S and 18S rRNA genes) with drug-resistance gene (example mapping in list).
    0130UTargeted mRNA sequence analysis panel (hereditary colon cancer disorders) (List separately).
    0140UFungal pathogen identification, DNA (15 fungal targets), blood culture, amplified probe technique.
    0152UMicrobial cell-free DNA, plasma, untargeted next-generation sequencing.
    0211UOncology pan-tumor DNA and RNA by next-generation sequencing, interpretative report with therapy association.
    0244UOncology comprehensive genomic profiling, 257 genes, FFPE tumor tissue.
    0279UVon Willebrand factor and collagen III binding by ELISA, plasma.
    Examples from windowed listmixed
    0270UGenomic sequence analysis (various hematology panels) — multiple entries
    0274TPercutaneous laminotomy/laminectomy (interlaminar approach)
    Additional examplesmixed
    0335UWhole genome sequence analysis (rare/constitutional disorders)
    0358UNeurology (mild cognitive impairment) CSF B-amyloid 1-42/1-40 assay
    sample codes from partial listmixed
    0350TRadiostereometric analysis (RSA); lower extremity(ies) including hip, proximal femur, knee, and ankle when performed
    0355UAPOL1 risk variants (G1, G2)
    0395THigh dose rate electronic brachytherapy, interstitial or intracavitary treatment, per fraction
    0478UDigital PCR analysis of 9 genes in FFPE tissue for actionable variants (NSCLC panel)
    Selected codes (partial)mixed
    0473TDevice evaluation and interrogation of intraocular retinal electrode array; includes reprogramming and visual training
    0473UOncology NGS of DNA (648 genes) from FFPE with matched normal, reports variants, CNVs, rearrangements, MSI, and TMB
    0474TInsertion of anterior segment aqueous drainage device into supraciliary space
    0474UHereditary pan-cancer genomic panel (88 genes) germline sequencing
    Selected codes from continuation listCPT
    0588TPosterior tibial nerve electronic analysis/simple programming of implanted neurostimulation system
    0589TElectronic analysis with simple programming of implanted integrated neurostimulation system for bladder dysfunction
    0590TElectronic analysis with complex programming of implanted integrated neurostimulation system for bladder dysfunction, posterior tibial nerve, 4+ parameters
    0591THealth and well-being coaching face-to-face; individual, initial assessment
    0592THealth and well-being coaching face-to-face; individual, follow-up session, >=30 minutes
    0593THealth and well-being coaching face-to-face; group, >=30 minutes
    0594TOsteotomy, humerus, with insertion of externally controlled intramedullary lengthening device
    0596TTemporary female intraurethral valve-pump; initial insertion
    0597TTemporary female intraurethral valve-pump; replacement
    0598TReal-time fluorescence wound imaging; first anatomic site
    inv-48: Effective dates noted for specific codes in excerpt
    Examples of effective dates on codes00170 Effective Date = 1/2/2020; 11950-11954 Effective Date = 1/2/2020; 14041 Effective Date = 1/1/2024
    Range of dates shown in excerptDates in list examples span 1/2/2020 to 1/1/2024 in this excerpt
    Purpose of date fieldEffective Date entries indicate when the code mapping/notation was recorded for prior authorization listing
    inv-49: Effective date notes present
    Presence of date annotationsSeveral CPT entries include explicit date annotations (examples: 22859 = 10/1/2018; 27125 = 10/1/2018)
    Common formatCodes are followed by inline effective/mapping dates in MM/DD/YYYY format
    InterpretationThese date notes reflect when the code was added or updated on the commercial PA/notification list
    inv-50: Effective/activation dates present
    Therapeutic radiology planning effective dates77306, 77307, 77316-77318, 77321, 77331, 77332 show Effective Date = 10/1/2021
    Radiation delivery effective dates77372, 77373, 77387, 77399, 77402, 77407, 77412 show Effective Date = 10/1/2021
    Functional meaningEffective/activation dates indicate the date the radiology codes were recorded/activated on the list
    inv-51: No numeric utilization thresholds specified in excerpt
    Utilization thresholds presentNo numeric utilization thresholds (eg, frequency limits, numeric utilization caps) are specified in this excerpt
    What is provided insteadCode entries include descriptions and effective dates but not numeric utilization limits
    Implication for providersAuthorization decisions rely on code inclusion and clinical criteria elsewhere rather than numeric thresholds in this segment
    inv-52: codes_with_effective_dates
    Codes shown with inline datesExamples: 77306 = 10/1/2021; 77372 = 10/1/2021; 77402 = 10/1/2021
    Date examples across listMany code lines include explicit mapping/effective dates (eg, 8/1/2018, 9/1/2018, 10/1/2021)
    UsageThese in-line dates are used to indicate when the code entry became active or was last mapped on the PA/notification list
    inv-53: Minimum genes required for panels
    Minimum gene counts specifiedExamples: Hereditary cardiomyopathy panels must include sequencing of at least 5 genes; Noonan spectrum panels must include at least 12 genes
    Hearing loss panels requirementHearing loss genomic panels must include sequencing of at least 60 genes (sample gene list provided)
    XLID panels exampleX-linked intellectual disability (XLID) panels must include sequencing of at least 60 genes
    inv-54: Algorithmic results reported as categorical or risk scores
    Algorithmic/assay outputs describedSeveral gene-expression and molecular assays report algorithmic outputs such as recurrence or risk scores (eg, 81503, 81519; 0287U reported as categorical risk result)
    Reported formatsAlgorithm results are described as categorical risk levels (low/intermediate/high) or numeric/recurrence risk scores
    Examples in list0356U and 0287U entries reference algorithm-reported prognostic or categorical risk results
    inv-55: Oncology NGS gene counts
    Large oncology NGS panels cited0473U = NGS of 648 genes from FFPE with matched normal; 0334U = targeted genomic sequence analysis, 84+ genes
    ctDNA and plasma NGS examples0487U = cell-free circulating DNA targeted NGS panel of 84 genes; 0486U = NGS of tumor methylation markers in ctDNA
    Actionable detailExample: 0473U lists 648 genes (comprehensive oncology NGS), useful for therapy selection and PA assessment

    What providers must do: submission, notification, and authorization

    Prior Authorization

    Obtain prior authorization and submit via portal

    Prior Authorization is required for services listed on the Commercial Prior Authorization/Notification List. Submit requests via the secure provider portal (registered users can log in to submit an electronic preauthorization request). For help, call the number on the member's ID card or contact your Provider Relations Representative. Note: prior authorization is not a guarantee of payment; verify member benefits, eligibility, and plan limits.

    • Prior authorization required for listed services.
    • Submit via secure provider portal; phone number on member ID card for assistance.
    • Prior authorization does not guarantee payment; verify benefits and eligibility.
    Documentation Required

    Provide notification for requested services

    For certain services the plan requests notification (notification-only) to assist with discharge planning, care coordination, and case management; providers should notify the plan per payer procedures.

    • Notification is requested (notification-only) for certain services to support discharge planning, care coordination, and case management.
    • Refer to payer procedures for how to provide notifications.
    Prior Authorization

    Check list for CPT codes requiring prior authorization/notification

    The list includes many CPT procedure codes that require prior authorization or notification; examples shown include spine codes 22515, 22526, 22527, 22532, 22533. Providers must check the full list and obtain prior authorization where indicated.

    • Example codes requiring prior authorization/notification: 22515, 22526, 22527, 22532, 22533.
    • Always reference the full Commercial Prior Authorization/Notification List for complete codes and effective dates.
    Prior Authorization

    Obtain prior authorization for listed hip procedures

    Hip and related arthroplasty CPT codes are included on the list (examples: 27125, 27130, 27132, 27134, 27137, 27138); prior authorization must be obtained when these codes are being billed per the list.

    • Hip-related codes listed: 27125, 27130, 27132, 27134, 27137, 27138.
    • Obtain prior authorization when performing these hip procedures per the Commercial PA/Notification List.
    Prior Authorization

    Prior authorize knee arthroscopy/arthroplasty codes

    Knee arthroscopy and arthroplasty procedure codes such as 29867, 29868, 29870, and 29871 are included on the prior authorization/notification list; obtain prior authorization as required.

    • Knee codes on the list include: 29867, 29868, 29870, 29871.
    • Prior authorization required for listed knee arthroscopy/arthroplasty services.
    Prior Authorization

    Secure prior authorization for knee/hip arthroscopy codes

    Additional knee and hip arthroscopy codes (eg, 29874–29889 and 29914–29916) appear on the list with effective dates; providers must secure prior authorization when these codes apply.

    • Included arthroscopy codes: 29874–29889 (knee) and 29914–29916 (hip).
    • Effective dates are shown inline on the list; consult the list for date-specific mappings.
    Prior Authorization

    Obtain prior authorization for rhinoplasty/nasal procedures

    Rhinoplasty and nasal surgery CPT codes (examples: 30400, 30410, 30420, 30430, 30435, 30450, 30460, 30468) are on the PA/notification list; obtain prior authorization per the list when billing these procedures.

    • Rhinoplasty/nasal valve repair codes on the list include 30400, 30410, 30420, 30430, 30435, 30450, 30460, 30468.
    • Check effective/mapping dates on the list when submitting authorization requests.
    Prior Authorization

    Prior authorization for thoracic, transplant and related cardiac procedures

    Various thoracic, bronchial, lung transplant and cardiac procedure codes are included on the list (examples include bronchial procedures and transplant-related codes); providers must obtain prior authorization per the code entries and effective dates.

    • Examples of included codes relate to bronchoscopy with bronchial thermoplasty and lung transplant mappings.
    • Refer to the list for specific cardiac and transplant procedure codes and their effective dates.
    Prior Authorization

    Prior authorization for cardiac, transplant, and VAD procedures

    Cardiac procedures and ventricular assist device (VAD) related codes (examples listed in the document) require prior authorization or notification as indicated on the list; verify the exact code and effective date before submission.

    • Cardiac/transplant/VAD procedure codes are listed with effective dates (see list entries).
    • Verify the specific CPT and effective date on the Commercial PA/Notification List before requesting authorization.
    Prior Authorization

    Obtain prior authorization for venous and vascular procedures

    Venous and vascular procedures (including sclerotherapy and endovenous ablation) such as 36465, 36466, 36473, 36474, 36475, 36478, 36483, 36836, 36837, 37700 and related codes are listed; obtain prior authorization per the list.

    • Examples of venous/vascular codes on the list: 36465–36471, 36473–36483, 36836–36837, 37700, 37718, 37722.
    • Prior authorization required for listed venous and endovenous ablation services; check effective dates.
    Prior Authorization

    Prior authorization for transplant, HPC and bariatric/gastric procedures

    Transplant preparation and hematopoietic progenitor cell (HPC) codes (examples: 38206–38214, 38240–38241) and bariatric/gastric procedure codes (eg, 43210, 43290–43291, 43644–43648, 43770–43773) are included on the list; prior authorization must be obtained when these services are provided.

    • HPC/transplant codes listed include 38206–38214 and 38240–38241.
    • Bariatric/gastric procedure codes listed include 43210, 43290–43291, 43644–43648, 43770–43773.
    • Obtain prior authorization per the Commercial PA/Notification List for these transplant and bariatric services.
    Prior Authorization

    Reference the PA/notification code list when requesting authorization

    The PA/notification list contains numerous CPT, category III (T), and proprietary (U) codes used for prior authorization/notification processing; providers must reference the list when submitting requests.

    • The list enumerates CPT and unlisted procedure codes that are part of the commercial prior authorization/notification list.
    • Providers must reference the list for correct codes and any mapping or effective dates when submitting authorizations.
    Prior Authorization

    Use exact code and effective date when requesting authorization

    The document excerpt lists CPT procedure codes that require prior authorization or notification and often shows an associated effective or mapping date; providers should use the listed code and date when submitting authorization requests.

    • Many code entries include an effective/mapping date shown inline (eg, 10/1/2018, 1/2/2020, 4/1/2020, 10/1/2021).
    • Use the exact code and associated date from the list when initiating a prior authorization or notification.
    Note
    Prior Authorization

    Prior authorization for therapeutic radiology planning and devices

    Therapeutic radiology planning and device codes (examples: 77306, 77307, 77316–77318, 77321, 77331–77332) are included on the list; prior authorization is required for listed treatment planning and device design services.

    • Therapeutic radiology planning codes on the list include 77306, 77307, 77316–77318, 77321, 77331, 77332.
    • Obtain prior authorization for listed radiotherapy planning and treatment device services per the list.
    Prior Authorization

    Prior authorization for radiation treatment delivery and management

    Radiation treatment delivery and management CPTs (examples: 77372–77373, 77402, 77407, 77412, 77425–77435 and treatment management codes) are included; prior authorization is required for these radiation delivery and management services per the list.

    • Radiation delivery codes on the list include stereotactic radiosurgery, SBRT, and Level 1–3 delivery codes (eg, 77372, 77373, 77402, 77407, 77412).
    • Treatment management and course-level codes (eg, 77425–77435) are listed and require authorization.
    Prior Authorization

    Obtain prior authorization for brachytherapy and hyperthermia codes

    Brachytherapy, hyperthermia, and related procedure codes (examples: 77610, 77750, 77761–77763, 77767–77772, 77778–77790) are listed and require prior authorization when billed as indicated.

    • Brachytherapy/hyperthermia codes listed include 77610, 77750, 77761–77763, 77767–77772, 77778–77790, 77799.
    • Obtain prior authorization for listed brachytherapy and hyperthermia services per the list.
    Prior Authorization

    Prior authorization for nuclear medicine and PET/SPECT studies

    Extensive nuclear medicine and PET/SPECT codes (eg, 78012–78020, 78103–78104, 78430–78432, 78451–78452, 78605–78610, 78630) are included on the list; prior authorization or notification is required for these studies per the list.

    • Nuclear medicine/myocardial PET and SPECT codes listed include 78430–78432, 78451–78452 and multiple 780xx/781xx/786xx codes.
    • Check the list for the specific nuclear medicine CPT and associated effective date when submitting authorization.
    Prior Authorization

    Verify prior authorization for nuclear medicine/radiopharmaceutical codes

    Numerous nuclear medicine codes across 786xx–788xx ranges and related radiopharmaceutical procedures are on the authorization/notification list; providers must obtain prior authorization or provide notification as specified.

    • Nuclear medicine/radiopharmaceutical code ranges on the list include 78605–78660, 78700–78730, 78800–78832.
    • Refer to the list for the exact CPT and effective/mapping date when requesting authorization.
    Prior Authorization

    Prior authorization for molecular pathology and genetic tests

    Molecular pathology and genetic testing CPTs (811xx, 812xx, 813xx, 814xx series) are included on the PA/notification list; providers must request prior authorization or notification for listed genetic tests and observe any test-specific requirements.

    • Genetic test codes listed include BRCA analyses (81162–81167, etc.) and molecular pathology procedure levels (81408–81412 and others).
    • Obtain prior authorization per the list and note any effective dates for specific genetic tests.
    Prior Authorization

    Ensure genomic panels meet listed gene-content requirements before authorization

    Genomic panels and molecular pathology entries specify minimum gene content or analysis requirements for certain panels (examples: aortic dysfunction panels must include sequencing of at least 9 named genes; hearing loss panels require copy number analyses for STRC and DFNB1/GJB2/GJB6; XLID panels must include at least 60 genes). Ensure ordered panels meet the listed panel content requirements when seeking authorization.

    • 81410 requires sequencing of at least 9 genes including FBN1, TGFBR1, TGFBR2, COL3A1, MYH11, ACTA2, SLC2A10, SMAD3, MYLK.
    • 81431 hearing loss panels must include copy number analyses for STRC and DFNB1 deletions in GJB2 and GJB6.
    • 81470 XLID panel must include sequencing of at least 60 specified genes.
    Prior Authorization

    Confirm panel size, analytes, and sample type for expanded genomic panels

    Expanded genomic sequence analysis panels and related molecular pathology CPTs (eg, 81455–81464 and others) appear on the list with gene-count thresholds and specimen-type notes (including cell-free/plasma); confirm panel size, analytes (DNA/RNA), and sample type when submitting prior authorization.

    • Examples include 81456 (solid organ neoplasm panels ≥51 genes), 81462–81464 (cell-free/plasma panels with various analytes).
    • Confirm DNA vs combined DNA/RNA testing and cell-free/plasma sample applicability per the list before requesting authorization.
    Prior Authorization

    Prior authorization for gene expression and assay-based tests

    Gene expression and algorithmic/assay-based tests (examples: 81503, 81504, 81518, 81519, 81520, 81521, 81522, 81523, 81525, 81529, 81535, 81541, 81560, 81595) are listed; these often report algorithmic risk scores or categorical results and require prior authorization per the list.

    • Listed assay codes include oncology and transplant gene expression profiling tests (eg, 81519 – 21-gene breast recurrence score; 81541 – prostate 46-gene profile).
    • Authorization requests should reference the listed code and note that algorithmic/risk score outputs are typical for these tests.
    Prior Authorization

    Verify authorization/notification for laboratory, reproductive and immunology codes

    Assorted laboratory, reproductive, immunology, vaccine and related CPTs (eg, 82523, 84999, 86015, 86036, 86037, 88267, 89250–89264, 90378–90381) are listed for notification or authorization; follow the list and effective dates when submitting.

    • Examples include reproductive medicine and cryopreservation codes (89250–89264) and immunology/vaccine codes (90378–90381).
    • Use the Commercial PA/Notification List to determine whether prior authorization or notification is required for these lab/reproductive codes.
    Prior Authorization

    Obtain authorization for imaging, ophthalmology, vestibular and cardiac codes

    Imaging, ophthalmology, vestibular, and numerous cardiac catheterization CPTs (examples: 91110–91113 capsule endoscopy, 92065 orthoptic training, 92549 CDP-SOT, 93451–93461 cardiac catheterization codes) are included on the list; obtain prior authorization or provide notification as indicated.

    • Imaging and cardiac catheterization codes listed include 93451–93461 and related procedural codes with effective dates.
    • Vestibular and ophthalmology services (eg, 92549, 92065) are listed—check the list before scheduling services.
    Prior Authorization

    Prior authorization for interventional, neurophysiology, psychological, and home health services

    Interventional cardiology, neurophysiology, neurodiagnostic, psychological testing, and home health supervision CPTs (examples: 93590–93597, 95905, 95940–95941, 96130–96131, 99374) are on the list; prior authorization or notification is required per the list entries and effective dates.

    • Interventional and neurophysiology codes on the list include 93590–93597, 95905, 95940–95941.
    • Psychological testing and home health supervision codes (96130–96131, 99374) are listed — follow the PA/notification process.
    Note

    Use the official PA/Notification list as the authorization reference

    Providers must reference the Commercial Prior Authorization/Notification List when seeking prior authorization or providing notification; the list contains code descriptions and effective/mapping dates used by the plan for authorization decisions.

    • Segment lists codes and descriptions that are part of the commercial PA/Notification List; providers must reference these.
    • The full, current list and submission instructions are available on the Baylor Scott & White Health Plan Service Portal.
    Prior Authorization

    Confirm authorization requirements for U/T proprietary and temporary codes

    The document includes many U- and T- proprietary codes and temporary tracking codes (eg, 0122U, 0350T, 0473U, 0474U, 0355U, 0395U, 0473T) used to identify molecular/genomic tests and emerging technologies; check the list for exact U/T code entries and effective dates before submitting authorization requests.

    • Examples of U/T codes in the list: 0122U, 0350T, 0355U, 0473U, 0474U, 0395U.
    • Confirm the exact U/T code and effective/mapping date on the Commercial PA/Notification List when requesting authorization.
    Documentation Required

    Include test/panel details and gene-count requirements in authorization requests

    When requesting authorization for molecular/genomic tests and procedural T-codes, include test details (panel name, gene count, specimen type) and reference any gene-content or panel-size requirements noted in the list to facilitate review.

    • Provide panel name, gene count, and specimen type (eg, FFPE tissue or plasma cell-free) when submitting authorization for genomic panels.
    • Reference the list's gene-content requirements (eg, minimum gene counts for specific panels) in the request.
    Prior Authorization

    Demonstrate panels meet minimum gene-content thresholds

    Some listed molecular/genomic tests specify minimum gene-content thresholds (examples: 81439 requires sequencing of at least 5 cardiomyopathy-related genes; 81442 requires at least 12 genes for Noonan spectrum panels; 81470 requires sequencing of at least 60 genes for XLID). Ensure authorization requests demonstrate the panel meets these minimums.

    • 81439 (hereditary cardiomyopathy) must include sequencing of at least 5 genes (eg, DSG2, MYBPC3, MYH7, PKP2, TTN).
    • 81442 (Noonan spectrum) must include sequencing of at least 12 genes (eg, BRAF, CBL, HRAS, KRAS, MAP2K1, MAP2K2, NRAS, PTPN11, RAF1, RIT1, SHOC2, SOS1).
    • 81470 (XLID) must include sequencing of at least 60 specified genes.
    Billing Rule

    Include exact CPT and effective date for radiation/nuclear medicine authorization

    For radiation and nuclear medicine services listed, use the exact CPT and effective date from the list (e.g., therapeutic radiology planning codes 77306, 77307, and radiation delivery codes 77402, 77407, 77412 show effective date 10/1/2021) when submitting prior authorization to avoid processing delays.

    • Examples of codes with 10/1/2021 effective dates: 77306, 77307, 77316–77318, 77402, 77407, 77412.
    • Include the listed effective/mapping date with the CPT when submitting authorization requests.
    Note

    Verify member eligibility and benefits before services

    Claims will be reviewed to determine member eligibility at time of service and benefit availability; prior authorization does not guarantee payment—providers must verify member benefits and eligibility before providing services.

    • Prior authorization is not a guarantee of payment; reimbursement depends on eligibility, benefit limits and exclusions.
    • Verify benefits via the member benefit booklet or customer service before providing services.
    Prior Authorization

    Confirm authorization for newly published or emerging codes

    Newly published or assigned codes and emerging therapy services not listed may still require prior authorization; check with Baylor Scott & White Health Plan before providing these services.

    • New or emerging codes/services may require prior authorization even if not yet listed.
    • Contact Baylor Scott & White Health Plan to confirm authorization requirements for new codes/technologies.

    Key terms and definitions

    inv-89: Prior Authorization
    Prior authorization definitionAn authorization process required before certain services are rendered; not a guarantee of benefits or payment and subject to member eligibility and plan limits.
    Where to submitProviders should use the Baylor Scott & White Health Plan secure provider portal to submit preauthorization requests and verify benefits
    Verification reminderAlways verify benefits via member benefit booklet or customer service as benefits vary by plan
    inv-90: Baylor Scott & White Health Plan (BSWHP)
    Entity referenceDocument refers collectively to Scott and White Health Plan dba Baylor Scott & White Health Plan and related subsidiaries as Baylor Scott & White Health Plan (BSWHP)
    Products describedHMO, PPO, EPO and self-funded plans are administered by entities in the Baylor Scott & White Health Plan family
    Contact routesProvider Relations and member ID card phone number referenced for assistance and portal access
    inv-91: Percutaneous vertebral augmentation (kyphoplasty)
    Procedure definition22515 — Percutaneous vertebral augmentation (kyphoplasty), including cavity creation, imaging guidance; each additional vertebral body listed
    Effective date example22515 mapping shows an associated date entry = 10/1/2018
    ContextIncluded on the commercial prior authorization/notification list as a spine procedure requiring PA/notification
    inv-92: Arthroplasty, total hip/knee
    Typical arthroplasty codes includedExamples mapped to PA list: 27125, 27130, 27132, 27134, 27137, 27138 (hip); 29867-29871 (knee arthroscopy/arthroplasty)
    Effective dates presentMany hip/knee entries include effective dates (eg, 27125 = 10/1/2018; 29867 = 10/1/2018)
    Implication for providersTotal hip and knee arthroplasty and related arthroscopy procedures are subject to prior authorization/notification per the list
    inv-93: Prior authorization/notification list
    List purposePrior authorization/notification codes excerpt enumerates CPT and unlisted procedure codes that require prior authorization or notification for commercial members
    Submission noteProviders must reference the code list when seeking prior authorization or providing notification
    No standalone clinical criteria hereThis excerpt provides code-level entries and effective dates but not detailed clinical coverage criteria
    inv-94: Commercial prior authorization/notification list
    Commercial PA/notification scopeThe Commercial prior authorization/notification list excerpt contains numerous CPT procedure codes across specialties with associated dates
    Provider actionInclusion on this commercial list indicates services require prior authorization or notification for commercial plans
    Where to find full listFull current list and online submission available on the Baylor Scott & White Health Plan Service Portal
    inv-95: Commercial Prior Authorization/Notification List (excerpt)
    Selected code groups shownTherapeutic radiology treatment planning (77306-77332) and radiation delivery (77372, 77402-77412) are included on the list with effective dates
    Effective/mapping datesRadiation planning and delivery codes show Effective Date = 10/1/2021 in the excerpt
    ImplicationRadiation oncology services listed require prior authorization/notification per commercial PA list
    inv-97: Therapeutic radiology treatment planning
    Therapeutic radiology planning definedCPT codes 77306-77332 describe teletherapy and brachytherapy isodose planning, dosimetry and treatment device design
    Radiation delivery levels definedCodes 77402-77412 define radiation treatment delivery levels (Level 1-3) including stereotactic radiosurgery and SBRT
    List inclusionThese therapeutic radiology codes are on the PA/notification list and display effective dates in the excerpt
    inv-98: Radiation treatment delivery levels
    Delivery code examples77402 (Level 1), 77407 (Level 2), 77412 (Level 3) — all shown with Effective Date = 10/1/2021
    ContextCodes describe levels of radiation treatment delivery and associated image guidance/management
    Provider implicationRadiation delivery services require prior authorization per the PA/notification list
    inv-99: Myocardial imaging PET/SPECT
    Myocardial imaging groupCPT range 78430-78499 for myocardial PET/SPECT perfusion/metabolic studies are included with dates (eg, 78430 = 4/1/2020)
    Example effective date78430 Effective Date = 4/1/2020; 78451/78452 show dates in 2018-2019 range
    ImplicationCardiac nuclear imaging services are listed for PA/notification and require verification per plan benefits
    inv-100: Molecular pathology procedure levels
    Molecular pathology levels explainedMolecular pathology Level 8 examples: analysis of 26-50 exons or multi-gene panels; Level 9: analysis of >50 exons
    Panel examplesCodes 81408-81443 include multi-gene panels and sequencing/duplication/deletion analyses listed with effective dates
    Provider noteInclusion of molecular pathology CPTs implies PA/notification requirement for listed genomic tests
    inv-101: Genomic sequence analysis panel
    Genomic panel entries81430-81443 and 81455-81464 series enumerate genomic sequence analysis panels with gene-count and analysis requirements
    Cell-free/plasma panelsCodes 81462-81464 include cell-free (plasma) genomic sequence analysis panels (ctDNA) with specified analyses
    Examples81462 = cell-free nucleic acid (plasma) interrogation for sequence variants; 81463/81464 include copy number, MSI, TMB where noted
    inv-102: Gene expression/assay-based test
    Assay-based/gene expression tests includedCodes such as 81503, 81519, 81541 reference mRNA gene expression profiling and algorithm-reported recurrence/risk scores
    Sample types and outputsEntries describe sample types (eg, whole blood, FFPE tissue) and algorithm outputs (risk/recurrence scores, tissue similarity)
    Clinical areasGene expression assays listed include oncology, cardiology and transplant applications
    inv-103: Commercial Prior Authorization/Notification List (codes)
    Examples of PLA/U codes0001U (RBC antigen DNA typing 35 antigens), 0003U (ovarian biochemical assay with algorithm likelihood score), 0005U (prostate gene expression risk score)
    U/T codes presenceMultiple U/T proprietary or temporary codes are listed for specialized lab/genomic tests requiring PA/notification
    Where usedThese PLA/U codes identify emerging or proprietary laboratory tests for PA processing
    inv-104: Proprietary or temporary CPT/HCPCS-like codes used to identify specific laboratory tests, genomic analyses, and procedures listed for prior authorization/notification.
    Temporary/proprietary codes definedU/T codes (eg, 0122U, 0130U, 0277U) are used to identify specific laboratory, genomic and emerging tests on the PA list
    Examples0122U = targeted sequence analysis (1/1/2023); 0277U = hematology genomic sequence analysis of 40 genes (1/1/2022)
    Provider implicationThese codes may require PA/notification and often include effective dates and test descriptors
    inv-105: Algorithmic test result
    Algorithmic test result example0287U and 0356U entries reference algorithm-reported categorical prognostic or recurrence risk results (eg, low/intermediate/high)
    DefinitionAlgorithmic test result = interpretation reported as a recurrence risk score or categorical result
    Implication for PAAlgorithm outputs are recorded in the list and used to guide clinical interpretation during prior authorization review
    inv-106: Whole genome sequence analysis
    Whole genome sequencing examples0335U/0336U = Whole genome sequence analysis for rare/constitutional disorders including SNVs, CNVs, mitochondrial analysis, STR expansions; effective date = 1/1/2023
    ScopeWGS entries include comprehensive variant types (small sequence changes, CNVs, large deletions, mitochondrial heteroplasmy, STRs)
    PA implicationWhole genome sequence analysis is listed and requires prior authorization/notification per the commercial list
    inv-107: Commercial Prior Authorization/Notification List (partial)
    NGS examples in U/T series0211U, 0244U, 0473U, 0478U and others denote next-generation sequencing panels for oncology and solid tumors (varying gene counts)
    ctDNA example0487U and 0486U reference cell-free circulating tumor DNA (ctDNA) panels and methylation analysis in plasma
    ImplicationNGS and ctDNA tests on the list require PA/notification and include gene counts or analytic scope where specified
    inv-108: next-generation sequencing
    Next-generation sequencing (NGS) shorthandNGS referenced throughout list for tumor and germline panels; entries specify gene counts and analytic details
    ctDNA shorthandCell-free circulating tumor DNA (ctDNA) panels (eg, 0487U, 0486U) are listed with plasma sample type and analytic endpoints
    Provider actionConfirm PA/notification requirements for NGS/ctDNA tests via service portal and benefit verification
    inv-109: cell-free circulating tumor DNA
    ctDNA entry example0487U — cell-free circulating DNA targeted genomic panel of 84 genes for solid tumor interrogation (Effective 7/1/2025)
    DefinitionCell-free circulating tumor DNA (ctDNA) used to describe plasma-derived tumor DNA assays included on the list
    ImplicationctDNA assays are included on the PA/notification list and specify analytic scope (eg, gene count, MSI, TMB) where applicable
    inv-110: Category III / temporary CPT codes
    Category III / temporary CPT examplesExamples include 0355U, 0356U, 0358T, 0588T-0590T and multiple 05xxT codes listed with effective dates
    PurposeCategory III / temporary CPT codes are used to track emerging technologies, procedures, and tests for PA/notification processing
    Provider noteThese temporary codes appear with effective dates and descriptors on the commercial PA/notification list
    Policy Summary
    PayerBaylor Scott & White Health Plan
    PolicyCommercial Prior Authorization / Notification List (partial)
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJun 1, 2026
    Next Review DateN/A
    Key ActionSubmit prior authorization requests via the secure provider portal and verify member benefits before providing services.
    SourceLink
    On This Page
    Coverage determinations and code inclusionsCPT, HCPCS, and proprietary codes (grouped)What providers must do: submission, notification, and authorizationKey terms and definitions